<DOC>
	<DOCNO>NCT01429701</DOCNO>
	<brief_summary>Dermatitis eczematous recurrent pruritic skin disorder significant morbidity impair quality life due specially pruritus physical visible skin lesion . The purpose trial evaluate effectiveness two different topic association drug .</brief_summary>
	<brief_title>Effectiveness Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol Acute Sub-acute Dermatitis Eczematous</brief_title>
	<detailed_description>Study design : - Experiment duration : 22 day - 2 visit ( day 0,7,15 22 ) - Reducing eczema area severity index evaluation - Adverse event evaluation - Double blind , non-inferiority , prospective parallel-group , intend treat trial .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Polymyxin B</mesh_term>
	<mesh_term>Polymyxins</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<criteria>1 . Patients must able understand study procedure agree participate give write consent . 2 . Patients acute subacute dermatitis minimum 3 symptom . 1 . Pregnancy risk pregnancy . 2 . Lactation 3 . Use antiinflammatory immunosuppressive drug ( last 30 day prior study ) . 4 . Sunlight exposure last 15 day . 5 . Any pathology past medical condition interfere protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Dermatitis</keyword>
	<keyword>Dermatitis , Atopic</keyword>
</DOC>